Q3 2025 · 13F-HR
Blue Owl Capital Holdings LPholdings as filed
Filed 2025-11-12 · accession 0001193125-25-276307
$322.1M
Reported value
72
Positions
2025-09-30
Period end
The Brief · Blue Owl Capital Holdings LP · Q3 2025
AI · grounded in 13F
Blue Owl Capital Holdings LP established a new position in NCDL valued at $42.7M. The fund also initiated stakes in OBDC for $26.1M and ENGENE HOLDINGS INC for $22.4M. Additional new positions include LRMR at $18.9M and EVCM at $18.3M.
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 67090S108 | NCDL | NUVEEN CHURCHILL DIRECT LEND | $42.7M | 13.2% | 3,091,553 | Common | SOLE |
| 69121K104 | OBDC | BLUE OWL CAPITAL CORPORATION | $26.1M | 8.11% | 2,045,070 | Common | SOLE |
| 29286M105 | — | ENGENE HOLDINGS INC | $22.4M | 6.95% | 3,278,106 | Common | SOLE |
| 517125100 | LRMR | LARIMAR THERAPEUTICS INC | $18.9M | 5.87% | 5,853,040 | Common | SOLE |
| 29977X105 | EVCM | EVERCOMMERCE INC | $18.3M | 5.67% | 1,641,929 | Common | SOLE |
| 43538H103 | HLLY | HOLLEY INC | $15.3M | 4.74% | 4,862,361 | Common | SOLE |
| G76279101 | ROIV | ROIVANT SCIENCES LTD | $15.0M | 4.64% | 988,249 | Common | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $14.9M | 4.62% | 2,510,972 | Common | SOLE |
| 90400D108 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $12.7M | 3.94% | 422,438 | Common | SOLE |
| 206787103 | CNDT | CONDUENT INC | $12.5M | 3.87% | 4,456,848 | Common | SOLE |
| 786700104 | SGMT | SAGIMET BIOSCIENCES INC | $9.1M | 2.83% | 1,328,351 | Common | SOLE |
| 20454B104 | CMPX | COMPASS THERAPEUTICS INC | $9.1M | 2.82% | 2,591,525 | Common | SOLE |
| 24703L202 | DELL | DELL TECHNOLOGIES INC | $7.4M | 2.30% | 52,334 | Common | SOLE |
| 17878Y207 | CVEO | CIVEO CORP CDA | $7.3M | 2.27% | 317,411 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $7.2M | 2.23% | 7,407,906 | Common | SOLE |
| 03843E104 | AQST | AQUESTIVE THERAPEUTICS INC | $7.0M | 2.17% | 1,250,000 | Common | SOLE |
| 254604101 | IRON | DISC MEDICINE INC | $6.8M | 2.10% | 102,260 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $6.1M | 1.88% | 3,443,659 | Common | SOLE |
| 697947109 | PVLA | PALVELLA THERAPEUTICS INC NE | $6.0M | 1.85% | 95,259 | Common | SOLE |
| 30233G209 | EYPT | EYEPOINT PHARMACEUTICALS INC | $5.2M | 1.62% | 367,594 | Common | SOLE |
| 500946108 | KRRO | KORRO BIO INC | $5.0M | 1.56% | 105,000 | Common | SOLE |
| 45175G207 | IMA | IMAGENEBIO INC | $4.4M | 1.37% | 540,924 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $4.4M | 1.36% | 2,969,199 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $4.1M | 1.28% | 169,450 | Common | SOLE |
| 45254E107 | IMRX | IMMUNEERING CORP | $3.9M | 1.20% | 550,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $3.8M | 1.19% | 100,944 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $3.5M | 1.08% | 604,914 | Common | SOLE |
| H0036K147 | ADCT | ADC THERAPEUTICS SA | $2.9M | 0.91% | 733,568 | Common | SOLE |
| G6683N103 | NU | NU HLDGS LTD | $2.8M | 0.86% | 173,873 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $2.6M | 0.80% | 1,250,000 | Common | SOLE |
| 28617K101 | ELDN | ELEDON PHARMACEUTICALS INC | $2.5M | 0.79% | 979,912 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $2.2M | 0.68% | 26,823 | Common | SOLE |
| 483497103 | KALV | KALVISTA PHARMACEUTICALS INC | $1.5M | 0.47% | 125,000 | Common | SOLE |
| 29103K100 | FLD | FOLD HLDGS INC | $1.4M | 0.45% | 856,632 | Common | SOLE |
| 654484153 | NIOBW | NIOCORP DEVS LTD | $1.0M | 0.31% | 546,442 | Common | SOLE |
| 87583X109 | TNGX | TANGO THERAPEUTICS INC | $1.0M | 0.31% | 119,416 | Common | SOLE |
| 293792107 | EPD | ENTERPRISE PRODS PARTNERS L | $978,438 | 0.30% | 31,290 | Common | SOLE |
| 37637K108 | GTLB | GITLAB INC | $556,828 | 0.17% | 12,352 | Common | SOLE |
| 824430300 | SHFS | SHF HOLDINGS INC | $543,423 | 0.17% | 75,897 | Common | SOLE |
| 81764X103 | TTAN | SERVICETITAN INC | $499,512 | 0.16% | 4,954 | Common | SOLE |
| 57055L206 | MRKR | MARKER THERAPEUTICS INC | $494,724 | 0.15% | 554,250 | Common | SOLE |
| G75398118 | RZLVW | REZOLVE AI PLC | $469,977 | 0.15% | 292,930 | Common | SOLE |
| 020952107 | AMOD | ALPHA MODUS HLDGS INC | $454,154 | 0.14% | 394,078 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $269,657 | 0.08% | 1,718 | Common | SOLE |
| 724078100 | 62C | PIPER SANDLER COMPANIES | $210,623 | 0.07% | 607 | Common | SOLE |
| 84445C118 | SLND/WS | SOUTHLAND HLDGS INC | $165,952 | 0.05% | 860,302 | Common | SOLE |
| 020952115 | AMODW | ALPHA MODUS HLDGS INC | $144,187 | 0.04% | 1,854,665 | Common | SOLE |
| G1331C112 | BGLWW | BLUE GOLD LTD | $80,080 | 0.02% | 175,000 | Common | SOLE |
| 87169M113 | OPTXW | SYNTEC OPTICS HLDGS INC | $70,033 | 0.02% | 803,132 | Common | SOLE |
| 09263B116 | BKSY/WS | BLACKSKY TECHNOLOGY INC | $59,045 | 0.02% | 350,000 | Common | SOLE |
| 171756117 | DAICW | CID HOLDCO INC | $45,750 | 0.01% | 300,000 | Common | SOLE |
| 00791X209 | AEON | AEON BIOPHARMA INC | $34,247 | 0.01% | 42,353 | Common | SOLE |
| 23834J110 | DAVEW | DAVE INC | $31,194 | 0.01% | 28,750 | Common | SOLE |
| 53838J113 | LVWR/WS | LIVEWIRE GROUP INC | $29,040 | 0.01% | 400,000 | Common | SOLE |
| 29286M113 | — | ENGENE HOLDINGS INC | $25,631 | 0.01% | 36,100 | Common | SOLE |
| 104932116 | BNAIW | BRAND ENGAGEMENT NETWORK INC | $25,502 | 0.01% | 1,666,808 | Common | SOLE |
| M7S64L107 | PGYWW | PAGAYA TECHNOLOGIES LTD | $24,335 | 0.01% | 48,661 | Common | SOLE |
| G7606H116 | RDZNW | ROADZEN INC | $15,750 | 0.00% | 225,000 | Common | SOLE |
| G50716110 | NVNIW | NVNI GROUP LIMITED | $14,400 | 0.00% | 200,000 | Common | SOLE |
| 98944F117 | ZEOWW | ZEO ENERGY CORP | $13,750 | 0.00% | 250,000 | Common | SOLE |
| 09174P113 | BTMWW | BITCOIN DEPOT INC | $12,400 | 0.00% | 50,000 | Common | SOLE |
| 88165K119 | TVGNW | TEVOGEN BIO HLDGS INC | $11,100 | 0.00% | 200,000 | Common | SOLE |
| 53271X116 | LIMNW | LIMINATUS PHARMA INC. | $7,395 | 0.00% | 50,000 | Common | SOLE |
| G0705H111 | BDMDW | BAIRD MED INVT HLDGS LTD | $6,700 | 0.00% | 100,000 | Common | SOLE |
| 09769B115 | BSLKW | BOLT PROJS HLDGS INC | $6,667 | 0.00% | 166,666 | Common | SOLE |
| 71902K113 | CEROW | CERO THERAPEUTICS HLDGS INC | $2,992 | 0.00% | 224,930 | Common | SOLE |
| 485859110 | KPLTW | KATAPULT HOLDINGS INC | $2,720 | 0.00% | 400,000 | Common | SOLE |
| 738920115 | ASBPW | ASPIRE BIOPHARMA HLDGS INC | $1,495 | 0.00% | 50,000 | Common | SOLE |
| G9503X111 | WALDW | WALDENCAST PLC | $1,233 | 0.00% | 33,333 | Common | SOLE |
| 98400V119 | XBPEW | XBP GLOBAL HOLDINGS INC | $994 | 0.00% | 24,778 | Common | SOLE |
| 854936119 | SDSTW | STARDUST PWR INC | $447 | 0.00% | 16,666 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $98 | 0.00% | 18,347 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.